Anti-inflammatory effects of minocycline are mediated by retinoid signaling

[1]  G. Ricevuti,et al.  Neuroinflammation, immune system and Alzheimer disease: searching for the missing link , 2017, Aging Clinical and Experimental Research.

[2]  T. McEvoy,et al.  Minocycline: Rheumatoid Arthritis , 2016, Hospital pharmacy.

[3]  Paul Edison,et al.  Neuroinflammation in Alzheimer's disease: Current evidence and future directions , 2016, Alzheimer's & Dementia.

[4]  M. Goiny,et al.  Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice , 2016, Neurochemical Research.

[5]  J. Feldon,et al.  Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia , 2016, Translational Psychiatry.

[6]  C. Pantelis,et al.  Microglial activation and progressive brain changes in schizophrenia , 2016, British journal of pharmacology.

[7]  Janet K. Kern,et al.  Relevance of Neuroinflammation and Encephalitis in Autism , 2016, Front. Cell. Neurosci..

[8]  G. Réus,et al.  The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders , 2015, Neuroscience.

[9]  I. Heuser,et al.  Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions? , 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  D. Kelly,et al.  Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms , 2015, Journal of clinical psychopharmacology.

[11]  I. Heuser,et al.  Inhibition of retinoic acid catabolism by minocycline: evidence for a novel mode of action? , 2015, Experimental dermatology.

[12]  T. Takano Role of Microglia in Autism: Recent Advances , 2015, Developmental Neuroscience.

[13]  M. Endres,et al.  Direct inhibition of retinoic acid catabolism by fluoxetine , 2015, Journal of Neural Transmission.

[14]  Alan A. Wilson,et al.  Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. , 2015, JAMA psychiatry.

[15]  Jeffrey F. Thompson,et al.  Attenuation of acute stroke injury in rat brain by minocycline promotes blood–brain barrier remodeling and alternative microglia/macrophage activation during recovery , 2015, Journal of Neuroinflammation.

[16]  J. Zohar,et al.  Early post-stressor intervention with minocycline, a second-generation tetracycline, attenuates post-traumatic stress response in an animal model of PTSD , 2015, European Neuropsychopharmacology.

[17]  K. Sawamoto,et al.  Minocycline treatment ameliorates interferon-alpha- induced neurogenic defects and depression-like behaviors in mice , 2015, Front. Cell. Neurosci..

[18]  G. Turecki,et al.  Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides , 2014, Brain, Behavior, and Immunity.

[19]  N. Iwata,et al.  Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta‐analysis of randomized controlled trials , 2014, Human psychopharmacology.

[20]  V. Võikar,et al.  Microglia are polarized to M1 type in high-anxiety inbred mice in response to lipopolysaccharide challenge , 2014, Brain, Behavior, and Immunity.

[21]  Marco Prinz,et al.  Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease , 2014, Nature Reviews Neuroscience.

[22]  I. Heuser,et al.  Do tetracyclines and erythromycin exert anti‐acne effects by inhibition of P450‐mediated degradation of retinoic acid? , 2014, Experimental dermatology.

[23]  S. Akhondzadeh,et al.  Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study , 2014, Psychiatry Research.

[24]  I. Heuser,et al.  Striking growth-inhibitory effects of minocycline on human prostate cancer cell lines. , 2014, Urology.

[25]  Takahiro A. Kato,et al.  Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model , 2013, Schizophrenia Research.

[26]  M. Endres,et al.  Accelerated degradation of retinoic acid by activated microglia , 2013, Journal of Neuroimmunology.

[27]  T. Elbert,et al.  Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells , 2013, BMC Psychiatry.

[28]  Y. Sekino,et al.  L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation , 2012, Journal of Neuroinflammation.

[29]  S. Janelidze,et al.  Connecting inflammation with glutamate agonism in suicidality , 2012, Neuropsychopharmacology.

[30]  J. O'Connor,et al.  Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge , 2012, Hormones and Behavior.

[31]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[32]  M. Furuya,et al.  Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  M. Berk,et al.  Minocycline: therapeutic potential in psychiatry. , 2012, CNS drugs.

[34]  G. Dunn,et al.  Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment , 2012, Journal of psychopharmacology.

[35]  Yuko Fujita,et al.  Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline , 2012, Pharmacology Biochemistry and Behavior.

[36]  C. Humpel,et al.  Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices , 2011, Neuroscience.

[37]  P. Chambon,et al.  Retinoid X Receptor Gamma Is Implicated in Docosahexaenoic Acid Modulation of Despair Behaviors and Working Memory in Mice , 2011, Biological Psychiatry.

[38]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[39]  R. Andrade,et al.  Enhanced Th17 phenotype in individuals with generalized anxiety disorder , 2010, Journal of Neuroimmunology.

[40]  J. Mey,et al.  Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid , 2010, Journal of Neuroimmunology.

[41]  Y. Levkovitz,et al.  A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. , 2010, The Journal of clinical psychiatry.

[42]  J. Gill,et al.  PTSD is associated with an excess of inflammatory immune activities. , 2009, Perspectives in psychiatric care.

[43]  B. Leonard,et al.  Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment , 2009, Pharmacopsychiatry.

[44]  R. Dantzer,et al.  Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice , 2009, Molecular Psychiatry.

[45]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[46]  Lu Chen,et al.  Retinoic acid regulates RARα-mediated control of translation in dendritic RNA granules during homeostatic synaptic plasticity , 2008, Proceedings of the National Academy of Sciences.

[47]  M. Molina-hernandez,et al.  Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[48]  J. Mey,et al.  RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases , 2008, Progress in Neurobiology.

[49]  M. Molina-hernandez,et al.  Antidepressant-like actions of minocycline combined with several glutamate antagonists , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[50]  J. Bremner,et al.  The neurobiology of retinoic acid in affective disorders , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[51]  Y. Oh,et al.  Minocycline Alleviates Death of Oligodendrocytes by Inhibiting Pro-Nerve Growth Factor Production in Microglia after Spinal Cord Injury , 2007, The Journal of Neuroscience.

[52]  Y. Levkovitz,et al.  Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia , 2007, Brain Research.

[53]  P. Scully,et al.  Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. , 2007, Journal of psychiatric research.

[54]  J. Koistinaho,et al.  Minocycline Provides Neuroprotection Against N-Methyl-d-aspartate Neurotoxicity by Inhibiting Microglia1 , 2001, The Journal of Immunology.

[55]  T. Pollmächer,et al.  Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.

[56]  E. Aviel,et al.  Pseudotumor cerebri induced by vitamin A combined with minocycline. , 1993, Annals of ophthalmology.

[57]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[58]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[59]  D. Friedman Medication-Induced Intracranial Hypertension in Dermatology , 2005, American journal of clinical dermatology.